FENC - Company ID 0001211583
The table below shows FENNEC PHARMACEUTICALS INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $41.25M | $40.18M | $21.95M | $18.70M | $22.68M | $40.32M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $72.50M |
| $66.88M |
| $46.06M |
| $40.79M |
| $42.98M |
| $57.97M |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $75.75M | $71.82M | $49.26M | $44.88M | $46.40M | $58.92M |
| Accounts payable | $5.52M | $6.28M | $5.87M | $5.94M | $5.28M | $3.87M |
| Total current liabilities | $12.39M | $9.59M | $9.81M | $8.41M | $8.37M | $7.43M |
| Long-term debt | - | - | $19.38M | $19.36M | $19.35M | $32.10M |
| Total liabilities | $33.31M | $34.15M | $53.75M | $52.34M | $52.28M | $64.09M |
| Retained earnings | -$227.25M | -$229.22M | -$224.64M | -$224.00M | -$220.85M | -$217.70M |
| Total equity | $42.44M | $37.67M | -$4.49M | -$7.46M | -$5.88M | -$5.17M |